drugset / Trial / NCT02186145

Efficacy and Safety Study of Metronidazole, Nystatin and Dexamethasone Combination Therapy in Bacterial and Fungal Vaginal Infections

NCT02186145

Phase 3 Unknown 160 enrolled Marjan Industria e Comercio ltda
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of association of metronidazole, nystatin and dexamethasone in the treatment of bacterial and fungal vaginal infections.

Timeline

Start
2016-01
Primary completion
2017-01
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.32 mg Other
Background Metronidazole Small molecule 500 mg Other
Background Nystatin Unknown 100000 iu Other

Indications